Intensive Review of Nephrology

Overview

Key Topics in Nephrology CME

This online CME course provides a comprehensive, case-based review of challenging clinical problems. Intensive Review of Nephrology sessions are led by nationally renowned speakers who discuss the practical application of physiological principles to the management of clinical problems, particularly for board exam preparation. Highlights include:

• Genetic testing for improved prognosis and therapy selection
• Introduction to point-of-care ultrasound: fundamentals for acquisition and interpretation
• Physical exam of the dialysis access
• Expanding the role of SGLT2i in diabetic and non-diabetic kidney disease
• Cases in cryptonephrology
• The new fundamentals in immunology and nephrology (it’s not just for transplant patients)

Topics / Speakers

Renal Physiology for the Boards - Melanie P. Hoenig, MD

Basic Concepts of Immunology in Autoimmune Kidney Disease - Ramon G. Bonegio, MD

Question and Answer Session - Faculty

Renal Pathology in 2021: Part 1 Nephritic Conditions - Helmut G. Rennke, MD

Renal Pathology in 2021: Part 2 - Astrid Weins, MD, PhD

Current Approaches to Urine Sediment Analysis - Martina M. McGrath, MD

Question and Answer Session - Faculty

IgA Nephropathy - Gerald B. Appel, MD

Membranous Nephropathy - Laurence H. Beck, Jr., MD, PhD

ANCA Vasculitis - John L. Niles, MD

Question and Answer Session - Faculty

Update on Lupus Nephritis - Gerald B. Appel, MD

Metabolic Management of Kidney Stones - Gary C. Curhan, MD, ScD

Anemia Management: Update and Best Practices - Ajay K. Singh, MBBS, FRCP (UK), MBA

Question and Answer Session - Faculty

Glomerulonephritis: Questions & Answers Session - Gerald B. Appel, MD

Must-Know Clinical Images in Nephrology - Ajay K.. Singh, MBBS, FRCP (UK), MBA

Must-Know Board Zebras - Emily S. Robinson, MD, MPH

Nephrology Board Review Practice 1 - Finnian R. McCausland, MB BCh, MMSc, FRCPI

Nephrology Board Review Practice 2 - Mallika Mendu, MD, MBA

Hyponatremia and Hypernatremia - Sodium Disorders - David B. Mount, MD

Hypokalemia and Hyperkalemia - Potassium Disorders - David B. Mount, MD

Question and Answer Session - Faculty

Acid-Base Disorders Part I - Anion Gap Metabolic Acidosis - Alan S.L. Yu, MB, BChir

Acid-Base Disorders II - Non-Gap Acidosis and Metabolic Alkalosis - Alan S.L. Yu, MB, BChir

Question and Answer Session - Faculty

Pregnancy and Renal Disease - Ravi I. Thadhani, MD, MPH

Treating Renal Patients with Rituximab in the Era of COVID-19 - David B. Mount, MD

Genetics and Kidney Disease - Friedhelm Hildebrandt, MD

Update on Polycystic Kidney Disease - Cristian Riella, MD

Question and Answer Session - Faculty

Pediatric Nephrology - Michael J.G. Somers, MD

Genetics: How to Integrate It into Practice - Ali Gharavi, MD

Social Determinants/Disparities in Renal Disease - Winfred W. Williams, Jr., MD

Question and Answer Session - Faculty

Electrolytes and Acid-Base Practice for the Boards - Part 1 - Alan S.L. Yu, MB, BChir

Electrolytes and Acid-Base Practice for the Boards - Part 2 - Alan S.L. Yu, MB, BChir

Chronic Kidney Disease in the Community: Meeting Them Where They Are - Li-Li Hsiao, MD, PhD, FACP

SPECIAL LECTURE — End-Stage Renal Disease in Areas of Armed Conflict: Challenges and Solutions - Sahar Koubar, MD

Why Do We Reject a Transplant? - Jamil R. Azzi, MD

Transplant Immunosuppression for the Boards - Steven Gabardi, PharmD, BCPS, FAST, FCCP

Question and Answer Session - Faculty

Immunological Assessment Pre and Post Transplant - Melissa Y. Yeung, MD and Indira Guleria, PhD

Early Post-Transplant Management - Anil K. Chandraker, MD

Question and Answer Session - Faculty

Evaluation of the Kidney Living Donor - Kassem Safa, MD

Late Loss of the Kidney Transplant - Andrew M. Siedlecki, MD

Infections in Transplant Recipients - Sarah P. Hammond, MD

Monitoring Kidney Transplant Patients: Beyond Creatinine - Saif Abdulkarim Muhsin, MB BCh

Pre-Transplant Surgical Evaluation of Recipients - Jamil R. Azzi, MD

Question and Answer Session - Faculty

Poisonings and Intoxications: What a Nephrologist Needs to Know - Timothy B. Erickson, MD

Late Post-Transplant Medical Complications - Leonardo V. Riella, MD, PhD

Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) - Jean M. Francis, MD

Geriatric Nephrology - Ernest I. Mandel, MD

COVID-19 Vaccination Response in Transplant Patients - Ann Woolley, MD

Immunologic Basis of Kidney Disease - Vivek Kasinath, MD

Use of Checkpoint Inhibitors in Kidney Transplant Recipients - Naoka Murakami, MD, PhD

Pre-Transplant Surgical Evaluation of Recipients - Sayeed Malek, MD

Transplant Cases: Board Review Practice - Melissa Y. Yeung, MD and Edgar L. Milford, Jr., MD

Transplant Board Review - Anil K. Chandraker, MD

Pathophysiology and Treatment of Diabetic Kidney Disease - Gearoid M. McMahon, MB BCh

Management of Hypertension after SPRINT - Richard J. Glassock, MD

Question and Answer Session - Faculty

Secondary Hypertension: Primary Aldosteronism and Pheochromocytoma - Anand Vaidya, MD, MMSc

Cardiorenal Syndrome - Finnian R. McCausland, MB BCh, MMSc, FRCPI

Liver and the Kidney - Andrew S. Allegretti, MD, MSc

Question and Answer Session - Faculty

Update on Renovascular Disease - Joseph M. Garasic, MD

Pathophysiology of Acute Kidney Injury - Joseph V. Bonventre, MD, PhD

Acute Kidney Injury Syndromes - Alice M. Sheridan, MD

ICU Nephrology and Continuous Renal Replacement Therapies - David J.R. Steele, MB BCh

Question and Answer Session - Faculty

Cancer and Acute Kidney Injury - Albert Q. Lam, MD

Paraprotein Induced Kidney Injury - Albert Q. Lam, MD

FSGS: A Lesion, Not a Disease - Richard J. Glassock, MD

Interstitial Nephritis: Overview for the Boards - Julie M. Paik, MD, ScD, MPH

APOL1 and Kidney Disease - Martin R. Pollak, MD

Question and Answer Session - Faculty

Dialysis Dosing - J. Kevin Tucker, MD

Mineral and Bone Disease - David Bushinsky, MD

Question and Answer Session - Faculty

Dialysis: A Case-Based Clinical Review and Update - J. Kevin Tucker, MD

Pearls in Mineral and Bone Disease - David Bushinsky, MD

Chronic Kidney Disease Epidemiology: A 2021 Update - Gearoid M. McMahon, MB BCh

Question and Answer Session - Faculty

Peritoneal Dialysis - Joanne M. Bargman, MD, FRCPC

Peritoneal Dialysis Complications - Joanne M. Bargman, MD, FRCPC

COVID-19 and Kidney Disease - Daniel Batlle, MD

Mesoamerican Nephropathy - Ricardo Correa-Rotter, MD

Dialysis Vascular Access: Assessment and Complications - Dirk M. Hentschel, MD

Renal Ultrasound for the Clinical Nephrologist - Adina S. Voiculescu, MD

Question and Answer Session - Faculty

Faculty

Accreditation / Pass Guarantee

Accreditation

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Harvard Medical School designates this enduring material for a maximum of 52 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: September 30, 2021
Termination Date: January 31, 2024 (Please note that AMA PRA Category 1 Credits ™ will no longer be issued for the activity after this date)
Estimated Time to Complete the Activity: 52 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

ABIM Medical Knowledge MOC Points

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 52 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

On the course evaluation page please indicate "Yes" when asked if you would like to receive ABIM MOC points for your participation in this enduring activity. You will then be required to provide your ABIM ID # and your Date of Birth. Points earned will equal the amount of AMA PRA Category 1 Credits™ claimed.

HMS will upload the participant data, including the points earned, directly to the ABIM so that it will appear on the ABIM diplomates transcript. These points will not appear on your certificate provided at the end of this enduring activity.

Disclosure Policy

Harvard Medical School (HMS) adheres to all ACCME Accreditation Criteria and Policies. It is HMS's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus.

Learning Objectives

After viewing this program, participants will be better able to:

• Summarize current/recommended nephrology guidelines in clinical practice
• Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
• Identify/integrate current therapeutic options for specific renal disorders
• Review and interpret up-to-date literature relevant to clinical practice
• Describe pathophysiological mechanisms as they apply to management of renal disease
• Synthesize teachings to better performance on the ABIM Nephrology certification/recertification examinations

ACGME Competencies

This course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:

• Patient Care and Procedural Skills
• Medical Knowledge
• Practice-Based Learning and Improvement

Target Audience

The target audience for the Intensive Review of Nephrology Course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees preparing for ABIM nephrology certification/recertification examinations and/or seeking a comprehensive update in renal medicine and its subspecialties.

Board Pass Guarantee

We Guarantee You'll Pass! Diligent course study and successful completion of the CME quiz provides the strongest likelihood of passing board certification or maintenance of certification exams. Oakstone is so confident of your success that we guarantee it. If you do not pass your exam on the first attempt, mail us a copy of your board failure notification, plus our system certificate reflecting your successful completion of the CME quizzes for the board review product purchased. You will receive a credit for the purchase price paid (less any discounts or premium), which you may apply to future purchases with Oakstone. Your exam record will be destroyed. Your board failure notification can be mailed to: Oakstone, P.O. Box 190165, Birmingham, AL 35219. If you have any questions on this policy, please feel free to contact Customer Service at 1-800-633-4743.

Quick Facts

Provider: from Brigham and Women’s Hospital and accredited by Harvard Medical School

Course Director:
Joseph V. Bonventre, MD, PhD
Harvard Medical School
Brigham and Women's Hospital

Anil K. Chandraker, MD
Harvard Medical School
Brigham and Women’s Hospital

Jamil R. Azzi, MD
Harvard Medical School
Brigham and Women's Hospital

Gearoid M. McMahon, MB BCh
Harvard Medical School
Brigham and Women's Hospital

Alice M. Sheridan, MD
Harvard Medical School
Brigham and Women's Hospital

Adina S. Voiculescu, MD
Harvard Medical School
Brigham and Women's Hospital

Credits: Earn a maximum of 52 AMA PRA Category 1 Credits™ and 52 ABIM MOC points